Once-daily Precision Timed Release™ (PTR™) stimulant designed to deliver rapid onset of effect and entire active-day duration ...
CTx-1301 is a novel proprietary formulation of dexmethylphenidate, a stimulant that increases norepinephrine and dopamine activity in the brain.
Understand the bidirectional relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) in transitional-age youth and apply ...
Stocktwits on MSN
Cingulate Stock Snaps 2-Day Losing Streak As Roth Hikes Target On ADHD Drug Review; Retail Bets On Buyout Potential
Retail chatter around Cingulate picked up on Tuesday after Roth Capital Partners raised its price target to $17 from $10 and ...
Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence based telehealth access for adults ...
Parenting is the best and the hardest job I’ve ever had. It’s a 24-7 job, even when your children are off to college or living independently. After the physical care is done and our children become ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Forbes Technology Council is an invitation-only, fee-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results